Brucellosis – new paradigms for a classical pathogen
نویسنده
چکیده
Introduction Globally, brucellosis remains one of, if not the major bacterial zoonosis, still devastating productivity of livestock and affecting mankind, either directly through infection, or indirectly through reduction of productivity among foodproducing livestock. It is estimated by the WHO that more than 500,000 new cases of human brucellosis occur each year. Many nations have deployed eradication campaigns, with some countries such as the UK and several other Northern European countries successfully gaining brucellosis-free status. Even in these countries, comprehensive surveillance is an essential prerequisite to maintain this status, exemplified by recent introductions of Brucella-infected cattle to the UK, despite preand post-export screening. The aetiological agent of brucellosis is a small, pleomorphic Gram-negative rod, which was first isolated from human clinical cases of undulant fever by David Bruce (1887). Later, in 1904, the Mediterranean Fever Commission under the leadership of David Bruce, identified the reservoir of infection in goats and subsequent transmission to man through consumption of unpasteurised milk. In subsequent years, similar microbes were identified in cattle (B. abortus) and swine (B. suis). This microbe belongs within the α-2 proteobacteria clustering with Bartonella, Ochrobactrum, Agrobacteria and Rhizobia as phylogenetic neighbours. The genus was originally divided into species based on various biochemical capabilities, dye and phage susceptibilities and host preferences (see Table). These species in some cases were further divided into biovars (see Table). Following whole genomic hybridization studies, the high degree of homogeneity among the brucellae was noted, prompting the re-classification into a single species, B. melitensis1. Although justifiable according to phylogenetic criteria, this classification has proved unpopular, largely through distinct host susceptibilities and differences in host-pathogen interactions. Brucellae generally possess two chromosomes with a large replicon of 2.1 Mbp (chromosome 1) and a smaller replicon of 1.2 Mbp (chromosome 2); however, B. suis biovar 3 possesses a single replicon of 3.1 Mbp. Plasmids have not been reported within the brucellae.
منابع مشابه
Vaccines and Vaccine Candidates against Brucellosis
Brucella is a facultative intracellular pathogen, and brucellosis is commonest zoonotic disease worldwide. Brucella species, isolated from domestic animals, are important pathogen for humans. Annually, more than 500,000 new cases of brucellosis are reported, and this figure is an underestimate due to extended under-reporting cases in several endemic countries. Brucella has a variety of virulenc...
متن کاملWindow of treatment initiation for human brucellosis, implications for treatment efficacy, and prevention of chronic infection.
TO THE EDITOR—Brucellosis is a common zoonotic infectious disease, with >500 000 new cases reported annually worldwide [1, 2]. Brucellosis is caused by the in-tracellular bacterial pathogen Brucella.
متن کاملNatural Resistance Against Brucellosis: A Review
Natural resistance against brucellosis was reviewed from historical and biological perspectives with regard to animals, humans and Brucella spp. Unfortunately, brucellosis continues to be a serious worldwide bacterial zoonosis of major significance to animal and human populations. Host genetic, innate and adaptive immune factors significantly influence the outcome of brucellosis as does the ena...
متن کاملBrucellosis caused by the wood rat pathogen Brucella neotomae: two case reports
BACKGROUND Brucellosis is a chronic bacterial disease caused by members of the genus Brucella. Among the classical species stands Brucella neotomae, until now, a pathogen limited to wood rats. However, we have identified two brucellosis human cases caused by B. neotomae, demonstrating that this species has zoonotic potential. CASES PRESENTATION Within almost 4 years of each other, a 64-year-o...
متن کاملPharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.
The rise of multidrug-resistant pathogens and the dearth of new antibiotic development place an existential strain on successful infectious disease therapy. Breakthrough strategies that go beyond classical antibiotic mechanisms are needed to combat this looming public health catastrophe. Reconceptualizing antibiotic therapy in the richer context of the host-pathogen interaction is required for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2006